Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 22 | 2025 | 2535 | 1.520 |
Why?
|
| Apolipoprotein E4 | 5 | 2025 | 62 | 0.760 |
Why?
|
| Papillomavirus Vaccines | 7 | 2019 | 168 | 0.730 |
Why?
|
| Florida | 17 | 2025 | 461 | 0.730 |
Why?
|
| Alzheimer Disease | 5 | 2025 | 971 | 0.710 |
Why?
|
| Anti-Anxiety Agents | 2 | 2018 | 17 | 0.650 |
Why?
|
| Parents | 6 | 2019 | 359 | 0.600 |
Why?
|
| Papillomavirus Infections | 7 | 2019 | 363 | 0.580 |
Why?
|
| Vaccination | 5 | 2024 | 332 | 0.470 |
Why?
|
| Anti-HIV Agents | 3 | 2025 | 475 | 0.440 |
Why?
|
| Humans | 53 | 2025 | 42113 | 0.420 |
Why?
|
| Residence Characteristics | 6 | 2022 | 358 | 0.420 |
Why?
|
| Female | 39 | 2025 | 23980 | 0.410 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2019 | 470 | 0.410 |
Why?
|
| Hepatitis C | 2 | 2025 | 138 | 0.400 |
Why?
|
| Depression | 3 | 2025 | 837 | 0.370 |
Why?
|
| Male | 32 | 2025 | 22745 | 0.360 |
Why?
|
| Adult | 27 | 2025 | 13437 | 0.360 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2022 | 36 | 0.360 |
Why?
|
| Cognition | 2 | 2025 | 458 | 0.340 |
Why?
|
| Cross-Sectional Studies | 14 | 2025 | 3073 | 0.340 |
Why?
|
| Viral Load | 5 | 2025 | 344 | 0.320 |
Why?
|
| Alcohol Drinking | 4 | 2022 | 585 | 0.310 |
Why?
|
| Substance-Related Disorders | 4 | 2024 | 825 | 0.300 |
Why?
|
| Developmental Disabilities | 2 | 2021 | 66 | 0.290 |
Why?
|
| Middle Aged | 20 | 2025 | 11790 | 0.290 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2020 | 959 | 0.280 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2018 | 350 | 0.280 |
Why?
|
| Sex Factors | 4 | 2021 | 1004 | 0.280 |
Why?
|
| Professional-Patient Relations | 2 | 2025 | 59 | 0.270 |
Why?
|
| Adolescent | 16 | 2022 | 5949 | 0.260 |
Why?
|
| Medication Adherence | 2 | 2025 | 177 | 0.250 |
Why?
|
| Young Adult | 13 | 2025 | 4928 | 0.250 |
Why?
|
| Minority Groups | 3 | 2025 | 663 | 0.230 |
Why?
|
| Emigrants and Immigrants | 2 | 2019 | 156 | 0.220 |
Why?
|
| Pyridoxal Phosphate | 2 | 2022 | 11 | 0.220 |
Why?
|
| Vitamin B 6 | 2 | 2022 | 7 | 0.220 |
Why?
|
| Smoking Cessation | 2 | 2022 | 583 | 0.220 |
Why?
|
| Employment | 3 | 2021 | 83 | 0.220 |
Why?
|
| United States | 11 | 2025 | 5068 | 0.220 |
Why?
|
| Physician-Patient Relations | 1 | 2025 | 146 | 0.210 |
Why?
|
| Apolipoproteins E | 1 | 2024 | 136 | 0.200 |
Why?
|
| Aged | 10 | 2025 | 7958 | 0.200 |
Why?
|
| Religion | 3 | 2019 | 90 | 0.200 |
Why?
|
| Haiti | 4 | 2025 | 86 | 0.200 |
Why?
|
| Continuity of Patient Care | 2 | 2020 | 118 | 0.180 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 39 | 0.180 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2024 | 225 | 0.180 |
Why?
|
| Anomie | 1 | 2021 | 6 | 0.180 |
Why?
|
| Vitamin B Complex | 1 | 2021 | 5 | 0.170 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 64 | 0.160 |
Why?
|
| Child | 8 | 2022 | 3381 | 0.160 |
Why?
|
| Food Supply | 1 | 2021 | 120 | 0.160 |
Why?
|
| Marketing | 1 | 2020 | 44 | 0.160 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 2790 | 0.160 |
Why?
|
| India | 5 | 2019 | 105 | 0.160 |
Why?
|
| Brain | 2 | 2025 | 1449 | 0.160 |
Why?
|
| Self Efficacy | 1 | 2021 | 211 | 0.150 |
Why?
|
| Trazodone | 1 | 2018 | 3 | 0.150 |
Why?
|
| Genotype | 4 | 2025 | 792 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2025 | 575 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2021 | 541 | 0.140 |
Why?
|
| Mother-Child Relations | 2 | 2016 | 61 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 570 | 0.140 |
Why?
|
| Adolescent Behavior | 1 | 2020 | 270 | 0.140 |
Why?
|
| Problem-Based Learning | 1 | 2018 | 41 | 0.140 |
Why?
|
| Autistic Disorder | 1 | 2018 | 38 | 0.130 |
Why?
|
| Poverty | 1 | 2021 | 395 | 0.130 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 188 | 0.130 |
Why?
|
| Socioeconomic Factors | 4 | 2025 | 1221 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 309 | 0.130 |
Why?
|
| Awareness | 1 | 2017 | 73 | 0.130 |
Why?
|
| Health Behavior | 1 | 2020 | 568 | 0.120 |
Why?
|
| Psychotherapy, Group | 1 | 2015 | 23 | 0.120 |
Why?
|
| Social Support | 1 | 2019 | 437 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2016 | 362 | 0.120 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 281 | 0.120 |
Why?
|
| Mood Disorders | 1 | 2015 | 54 | 0.120 |
Why?
|
| HIV-1 | 1 | 2021 | 747 | 0.110 |
Why?
|
| Health Policy | 1 | 2017 | 184 | 0.110 |
Why?
|
| Parental Consent | 1 | 2014 | 2 | 0.110 |
Why?
|
| Homosexuality, Male | 1 | 2020 | 483 | 0.110 |
Why?
|
| Hippocampus | 1 | 2018 | 591 | 0.110 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 1019 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2020 | 702 | 0.100 |
Why?
|
| Risk-Taking | 1 | 2016 | 456 | 0.100 |
Why?
|
| Prevalence | 3 | 2022 | 1593 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2019 | 641 | 0.100 |
Why?
|
| Anti-Retroviral Agents | 2 | 2023 | 158 | 0.090 |
Why?
|
| Rural Population | 3 | 2021 | 352 | 0.090 |
Why?
|
| Urban Population | 3 | 2021 | 364 | 0.090 |
Why?
|
| Organ Size | 2 | 2025 | 167 | 0.090 |
Why?
|
| Mothers | 3 | 2022 | 212 | 0.090 |
Why?
|
| Sexual Behavior | 1 | 2016 | 634 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 727 | 0.090 |
Why?
|
| Alcoholism | 1 | 2014 | 292 | 0.090 |
Why?
|
| Schools | 3 | 2018 | 283 | 0.080 |
Why?
|
| Perception | 2 | 2022 | 209 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 858 | 0.080 |
Why?
|
| Logistic Models | 3 | 2021 | 1001 | 0.080 |
Why?
|
| Nutrition Surveys | 2 | 2022 | 263 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2015 | 722 | 0.080 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2021 | 229 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 1051 | 0.070 |
Why?
|
| Nuclear Family | 2 | 2018 | 13 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 744 | 0.060 |
Why?
|
| Students | 2 | 2025 | 617 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2021 | 1728 | 0.060 |
Why?
|
| Educational Status | 2 | 2020 | 335 | 0.060 |
Why?
|
| Acculturation | 2 | 2019 | 203 | 0.060 |
Why?
|
| Atrophy | 1 | 2025 | 51 | 0.060 |
Why?
|
| Food Dispensers, Automatic | 1 | 2025 | 4 | 0.060 |
Why?
|
| Heterozygote | 1 | 2024 | 107 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2024 | 73 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2024 | 2466 | 0.050 |
Why?
|
| Social Values | 1 | 2022 | 31 | 0.050 |
Why?
|
| Risk Factors | 2 | 2021 | 3933 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2022 | 14 | 0.050 |
Why?
|
| Docosahexaenoic Acids | 1 | 2022 | 18 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2022 | 35 | 0.050 |
Why?
|
| Phosphates | 1 | 2022 | 54 | 0.050 |
Why?
|
| Cultural Characteristics | 1 | 2022 | 128 | 0.050 |
Why?
|
| Income | 1 | 2022 | 160 | 0.040 |
Why?
|
| Universities | 1 | 2025 | 539 | 0.040 |
Why?
|
| Heroin | 1 | 2020 | 18 | 0.040 |
Why?
|
| Parenting | 1 | 2022 | 135 | 0.040 |
Why?
|
| Fentanyl | 1 | 2020 | 16 | 0.040 |
Why?
|
| Nepal | 1 | 2020 | 18 | 0.040 |
Why?
|
| Sleep | 1 | 2022 | 179 | 0.040 |
Why?
|
| AIDS Serodiagnosis | 1 | 2020 | 25 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2022 | 253 | 0.040 |
Why?
|
| Financing, Government | 1 | 2020 | 20 | 0.040 |
Why?
|
| Linear Models | 1 | 2021 | 310 | 0.040 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2020 | 128 | 0.040 |
Why?
|
| Psychometrics | 1 | 2021 | 350 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 357 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 245 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 847 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1058 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 262 | 0.030 |
Why?
|
| Alleles | 1 | 2018 | 351 | 0.030 |
Why?
|
| Alabama | 1 | 2017 | 52 | 0.030 |
Why?
|
| Louisiana | 1 | 2017 | 49 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 512 | 0.030 |
Why?
|
| Mandatory Programs | 1 | 2016 | 5 | 0.030 |
Why?
|
| Virginia | 1 | 2016 | 12 | 0.030 |
Why?
|
| South Carolina | 1 | 2016 | 25 | 0.030 |
Why?
|
| Crime | 1 | 2016 | 29 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 584 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 1135 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 437 | 0.030 |
Why?
|
| Spouse Abuse | 1 | 2016 | 51 | 0.030 |
Why?
|
| Tennessee | 1 | 2016 | 88 | 0.030 |
Why?
|
| Physician's Role | 1 | 2016 | 39 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 288 | 0.030 |
Why?
|
| Condoms | 1 | 2016 | 148 | 0.030 |
Why?
|
| Smoking | 1 | 2022 | 1019 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 660 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 118 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 2015 | 125 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2014 | 64 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 680 | 0.030 |
Why?
|
| Marital Status | 1 | 2014 | 46 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2015 | 179 | 0.030 |
Why?
|
| School Health Services | 1 | 2014 | 89 | 0.020 |
Why?
|
| Health Status | 1 | 2016 | 432 | 0.020 |
Why?
|
| Mental Health | 1 | 2016 | 363 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1265 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1582 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2015 | 915 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1570 | 0.020 |
Why?
|